 | NB7 | Name: | N'-[(2-fluorophenyl)sulfonyl]benzohydrazide | Formula: | C13 H11 F N2 O3 S | SMILES: | c1(ccccc1S(NNC(c2ccccc2)=O)(=O)=O)F | InChi: | InChI=1S/C13H11FN2O3S/c14-11-8-4-5-9-12(11)20(18,19)16-15-13(17)10-6-2-1-3-7-10/h1-9,16H,(H,15,17) | Definition date: | 2019-05-10 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N'-[(2-fluorophenyl)sulfonyl]benzohydrazide |
|
 | NBJ | Name: | N'-[(2-fluorophenyl)sulfonyl]-3-iodobenzohydrazide | Formula: | C13 H10 F I N2 O3 S | SMILES: | C(c1cc(I)ccc1)(NNS(c2c(cccc2)F)(=O)=O)=O | InChi: | InChI=1S/C13H10FIN2O3S/c14-11-6-1-2-7-12(11)21(19,20)17-16-13(18)9-4-3-5-10(15)8-9/h1-8,17H,(H,16,18) | Definition date: | 2019-05-10 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N'-[(2-fluorophenyl)sulfonyl]-3-iodobenzohydrazide |
|
 | JFX | Name: | 4-fluoro-N-(3-methyl-1H-indazol-5-yl)butane-1-sulfonamide | Formula: | C12 H16 F N3 O2 S | SMILES: | Cc2c1c(ccc(c1)NS(CCCCF)(=O)=O)nn2 | InChi: | InChI=1S/C12H16FN3O2S/c1-9-11-8-10(4-5-12(11)15-14-9)16-19(17,18)7-3-2-6-13/h4-5,8,16H,2-3,6-7H2,1H3,(H,14,15) | Definition date: | 2019-06-12 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 4-fluoro-N-(3-methyl-1H-indazol-5-yl)butane-1-sulfonamide |
|
 | L7N | Name: | (~{E})-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylidene-[(4~{R})-3-oxidanylidene-1,2-oxazolidin-4-yl]azanium | Formula: | C11 H15 N3 O7 P | SMILES: | Cc1ncc(CO[P](O)(O)=O)c(C=[NH+][CH]2CONC2=O)c1O | InChi: | InChI=1S/C11H14N3O7P/c1-6-10(15)8(3-13-9-5-20-14-11(9)16)7(2-12-6)4-21-22(17,18)19/h2-3,9,15H,4-5H2,1H3,(H,14,16)(H2,17,18,19)/p+1/b13-3+/t9-/m1/s1 | Definition date: | 2019-07-26 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | (~{E})-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylidene-[(4~{R})-3-oxidanylidene-1,2-oxazolidin-4-yl]azanium |
|
 | LHT | Name: | hydrolysed ertapenem | Formula: | C22 H27 N3 O8 S | SMILES: | C[CH](O)[CH]([CH]1NC(=C(S[CH]2CN[CH](C2)C(=O)Nc3cccc(c3)C(O)=O)[CH]1C)C(O)=O)C(O)=O | InChi: | InChI=1S/C22H27N3O8S/c1-9-16(15(10(2)26)21(30)31)25-17(22(32)33)18(9)34-13-7-14(23-8-13)19(27)24-12-5-3-4-11(6-12)20(28)29/h3-6,9-10,13-16,23,25-26H,7-8H2,1-2H3,(H,24,27)(H,28,29)(H,30,31)(H,32,33)/t9-,10-,13+,14+,15-,16-/m1/s1 | Definition date: | 2019-08-19 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | (2~{S},3~{R})-2-[(2~{S},3~{R})-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-4-[(3~{S},5~{S})-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-3-methyl-2,3-dihydro-1~{H}-pyrrole-5-carboxylic acid |
|
 | 8JF | Name: | N-[5-(2,3-dimethylphenyl)-1,6-naphthyridin-7-yl]acetamide | Formula: | C18 H17 N3 O | SMILES: | c2cnc1cc(NC(=O)C)nc(c1c2)c3c(C)c(C)ccc3 | InChi: | InChI=1S/C18H17N3O/c1-11-6-4-7-14(12(11)2)18-15-8-5-9-19-16(15)10-17(21-18)20-13(3)22/h4-10H,1-3H3,(H,20,21,22) | Definition date: | 2019-10-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-[5-(2,3-dimethylphenyl)-1,6-naphthyridin-7-yl]acetamide |
|
 | M7V | Name: | (1S,2R)-2-[(S)-amino(carboxy)methyl]-1-butylcyclopropane-1-carboxylic acid | Formula: | C10 H17 N O4 | SMILES: | CCCCC1(C(C(C(O)=O)N)C1)C(O)=O | InChi: | InChI=1S/C10H17NO4/c1-2-3-4-10(9(14)15)5-6(10)7(11)8(12)13/h6-7H,2-5,11H2,1H3,(H,12,13)(H,14,15)/t6-,7-,10-/m0/s1 | Definition date: | 2019-03-27 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | (1S,2R)-2-[(S)-amino(carboxy)methyl]-1-butylcyclopropane-1-carboxylic acid |
|
 | M7Y | Name: | (2E)-3-[2-(3-cyclopentyl-5,5-dimethyl-2-oxoimidazolidin-1-yl)phenyl]-N-hydroxyprop-2-enamide | Formula: | C19 H25 N3 O3 | SMILES: | c1(c([C@H]=CC(=O)NO)cccc1)N3C(CN(C2CCCC2)C3=O)(C)C | InChi: | InChI=1S/C19H25N3O3/c1-19(2)13-21(15-8-4-5-9-15)18(24)22(19)16-10-6-3-7-14(16)11-12-17(23)20-25/h3,6-7,10-12,15,25H,4-5,8-9,13H2,1-2H3,(H,20,23)/b12-11+ | Definition date: | 2019-03-27 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | (2E)-3-[2-(3-cyclopentyl-5,5-dimethyl-2-oxoimidazolidin-1-yl)phenyl]-N-hydroxyprop-2-enamide |
|
 | M8G | Name: | N-{2-[(1E)-3-(hydroxyamino)-3-oxoprop-1-en-1-yl]phenyl}-2-phenoxybenzamide | Formula: | C22 H18 N2 O4 | SMILES: | c1cc(ccc1)Oc2ccccc2C(Nc3ccccc3C=CC(=O)NO)=O | InChi: | InChI=1S/C22H18N2O4/c25-21(24-27)15-14-16-8-4-6-12-19(16)23-22(26)18-11-5-7-13-20(18)28-17-9-2-1-3-10-17/h1-15,27H,(H,23,26)(H,24,25)/b15-14+ | Definition date: | 2019-03-27 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-{2-[(1E)-3-(hydroxyamino)-3-oxoprop-1-en-1-yl]phenyl}-2-phenoxybenzamide |
|
 | C7 | Name: | N-{2-[3-(hydroxyamino)-3-oxopropyl]phenyl}-3-(trifluoromethyl)benzamide | Formula: | C17 H15 F3 N2 O3 | SMILES: | O=C(NO)CCc1c(cccc1)NC(c2cc(ccc2)C(F)(F)F)=O | InChi: | InChI=1S/C17H15F3N2O3/c18-17(19,20)13-6-3-5-12(10-13)16(24)21-14-7-2-1-4-11(14)8-9-15(23)22-25/h1-7,10,25H,8-9H2,(H,21,24)(H,22,23) | Definition date: | 2019-03-27 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-{2-[3-(hydroxyamino)-3-oxopropyl]phenyl}-3-(trifluoromethyl)benzamide |
|
 | P1J | Name: | N-(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyl)-beta-alanine | Formula: | C8 H9 N3 O5 | SMILES: | C(C(O)=O)CNC(C=1NC(=O)NC(C=1)=O)=O | InChi: | InChI=1S/C8H9N3O5/c12-5-3-4(10-8(16)11-5)7(15)9-2-1-6(13)14/h3H,1-2H2,(H,9,15)(H,13,14)(H2,10,11,12,16) | Definition date: | 2019-07-23 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyl)-beta-alanine |
|
 | 8XY | Name: | 6-bromo-N-(1H-indol-4-yl)-1-benzothiophene-2-carboxamide | Formula: | C17 H11 Br N2 O S | SMILES: | c4c3cc(C(Nc1cccc2nccc12)=O)sc3cc(Br)c4 | InChi: | InChI=1S/C17H11BrN2OS/c18-11-5-4-10-8-16(22-15(10)9-11)17(21)20-14-3-1-2-13-12(14)6-7-19-13/h1-9,19H,(H,20,21) | Definition date: | 2017-03-18 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 6-bromo-N-(1H-indol-4-yl)-1-benzothiophene-2-carboxamide |
|
 | DKU | Name: | 3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one | Formula: | C25 H20 N2 O2 | SMILES: | Cc1ccc2n(c(CCC3=COc4ccccc4C3=O)nc2c1)c5ccccc5 | InChi: | InChI=1S/C25H20N2O2/c1-17-11-13-22-21(15-17)26-24(27(22)19-7-3-2-4-8-19)14-12-18-16-29-23-10-6-5-9-20(23)25(18)28/h2-11,13,15-16H,12,14H2,1H3 | Definition date: | 2019-08-09 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one |
|
 | DL0 | Name: | 6-chloranyl-3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one | Formula: | C25 H19 Cl N2 O2 | SMILES: | Cc1ccc2n(c(CCC3=COc4ccc(Cl)cc4C3=O)nc2c1)c5ccccc5 | InChi: | InChI=1S/C25H19ClN2O2/c1-16-7-10-22-21(13-16)27-24(28(22)19-5-3-2-4-6-19)12-8-17-15-30-23-11-9-18(26)14-20(23)25(17)29/h2-7,9-11,13-15H,8,12H2,1H3 | Definition date: | 2019-08-09 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 6-chloranyl-3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one |
|
 | DU9 | Name: | 6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-4-fluoranyl-1-methyl-1'-(8-methyl-4-oxidanylidene-3,5,6,7-tetrahydropyrido[2,3-d]pyrimidin-2-yl)spiro[indole-3,4'-piperidine]-2-one | Formula: | C27 H35 F N6 O3 | SMILES: | C[CH]1CN(C[CH](C)O1)c2cc(F)c3c(c2)N(C)C(=O)C34CCN(CC4)C5=NC6=C(CCCN6C)C(=O)N5 | InChi: | InChI=1S/C27H35FN6O3/c1-16-14-34(15-17(2)37-16)18-12-20(28)22-21(13-18)32(4)25(36)27(22)7-10-33(11-8-27)26-29-23-19(24(35)30-26)6-5-9-31(23)3/h12-13,16-17H,5-11,14-15H2,1-4H3,(H,29,30,35)/t16-,17+ | Definition date: | 2019-08-28 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 6-[(2~{S},6~{R})-2,6-dimethylmorpholin-4-yl]-4-fluoranyl-1-methyl-1'-(8-methyl-4-oxidanylidene-3,5,6,7-tetrahydropyrido[2,3-d]pyrimidin-2-yl)spiro[indole-3,4'-piperidine]-2-one |
|
 | DYR | Name: | 2-carbazol-9-yl-N-(2-chloranyl-6-cyano-phenyl)ethanamide | Formula: | C21 H14 Cl N3 O | SMILES: | Clc1cccc(C#N)c1NC(=O)Cn2c3ccccc3c4ccccc24 | InChi: | InChI=1S/C21H14ClN3O/c22-17-9-5-6-14(12-23)21(17)24-20(26)13-25-18-10-3-1-7-15(18)16-8-2-4-11-19(16)25/h1-11H,13H2,(H,24,26) | Definition date: | 2019-09-20 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 2-carbazol-9-yl-~{N}-(2-chloranyl-6-cyano-phenyl)ethanamide |
|
 | DYU | Name: | ~{N}-[2-(2,4-dimethylphenyl)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-3,4-dimethyl-benzamide | Formula: | C22 H23 N3 O S | SMILES: | Cc1ccc(n2nc3CSCc3c2NC(=O)c4ccc(C)c(C)c4)c(C)c1 | InChi: | InChI=1S/C22H23N3OS/c1-13-5-8-20(16(4)9-13)25-21(18-11-27-12-19(18)24-25)23-22(26)17-7-6-14(2)15(3)10-17/h5-10H,11-12H2,1-4H3,(H,23,26) | Definition date: | 2019-09-20 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | ~{N}-[2-(2,4-dimethylphenyl)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-3,4-dimethyl-benzamide |
|
 | DYX | Name: | 1-(4-chlorophenyl)-N-[2-(4-methoxyphenyl)-5,5-bis(oxidanylidene)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]cyclopentane-1-carboxamide | Formula: | C24 H24 Cl N3 O4 S | SMILES: | COc1ccc(cc1)n2nc3C[S](=O)(=O)Cc3c2NC(=O)C4(CCCC4)c5ccc(Cl)cc5 | InChi: | InChI=1S/C24H24ClN3O4S/c1-32-19-10-8-18(9-11-19)28-22(20-14-33(30,31)15-21(20)27-28)26-23(29)24(12-2-3-13-24)16-4-6-17(25)7-5-16/h4-11H,2-3,12-15H2,1H3,(H,26,29) | Definition date: | 2019-09-20 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 1-(4-chlorophenyl)-~{N}-[2-(4-methoxyphenyl)-5,5-bis(oxidanylidene)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]cyclopentane-1-carboxamide |
|
 | NWT | Name: | N-[(2S)-3-(3,5-difluorophenyl)-1-[[(3S,9S,13S,15R,19S,22S)-15,19-dimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl]amino]-1-oxopropan-2-yl]heptanamide | Formula: | C39 H52 F2 N6 O8 | SMILES: | CCCCC=CC(=O)N[CH](Cc1cc(F)cc(F)c1)C(=O)N[CH]2COC(=O)[CH]3C[CH](C)CN3C(=O)[CH](C)NC(=O)[CH]4CCCCN4C(=O)[CH]5CCCN5C2=O | InChi: | InChI=1S/C39H52F2N6O8/c1-4-5-6-7-13-33(48)43-28(19-25-17-26(40)20-27(41)18-25)34(49)44-29-22-55-39(54)32-16-23(2)21-47(32)36(51)24(3)42-35(50)30-11-8-9-14-45(30)38(53)31-12-10-15-46(31)37(29)52/h7,13,17-18,20,23-24,28-32H,4-6,8-12,14-16,19,21-22H2,1-3H3,(H,42,50)(H,43,48)(H,44,49)/t23-,24+,28+,29+,30+,31+,32+/m1/s1 | Definition date: | 2020-01-06 | Last modified: | 2020-03-20 | Release date: | 2020-03-25 |
|
 | GZ0 | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-3~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{S},5~{S},6~{S})-6-[(1~{S})-1,2-bis(oxidanyl)ethyl]-3,4,5-tris(oxidanyl)oxan-2-yl] hydrogen phosphate | Formula: | C17 H27 N5 O17 P2 | SMILES: | OP(OC1OC(C(C(C1O)O)O)C(O)CO)(=O)OP(=O)(O)OCC2C(O)C(C(O2)n3cnc4c3NC(=NC4=O)N)O | InChi: | InChI=1S/C17H27N5O17P2/c18-17-20-13-6(14(30)21-17)19-3-22(13)15-10(28)7(25)5(36-15)2-35-40(31,32)39-41(33,34)38-16-11(29)8(26)9(27)12(37-16)4(24)1-23/h3-5,7-12,15-16,23-29H,1-2H2,(H,31,32)(H,33,34)(H3,18,20,21,30)/t4-,5+,7+,8-,9-,10+,11-,12-,15+,16+/m0/s1 | Definition date: | 2020-01-31 | Last modified: | 2020-03-20 | Release date: | 2020-03-25 | Identifier: | [(2R,3S,4R,5R)-5-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S,5S,6S)-6-[(1S)-1,2-dihydroxyethyl]-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl dihydrogen diphosphate (non-preferred name) |
|
 | QNA | Name: | (1~{a}~{R},7~{b}~{S})-5-fluoranyl-2,2-bis(oxidanyl)-1~{a},7~{b}-dihydro-1~{H}-cyclopropa[c][1,2]benzoxaborinine-4-carboxylic acid | Formula: | C10 H9 B F O5 | SMILES: | OC(=O)c1c(F)ccc2[CH]3C[CH]3[B-](O)(O)Oc12 | InChi: | InChI=1S/C10H9BFO5/c12-7-2-1-4-5-3-6(5)11(15,16)17-9(4)8(7)10(13)14/h1-2,5-6,15-16H,3H2,(H,13,14)/q-1/t5-,6-/m1/s1 | Definition date: | 2019-11-24 | Last modified: | 2020-03-20 | Release date: | 2020-03-25 | Identifier: | (2~{S},4~{R})-9-fluoranyl-5,5-bis(oxidanyl)-6-oxa-5-boranuidatricyclo[5.4.0.0^{2,4}]undeca-1(11),7,9-triene-8-carboxylic acid |
|
 | LWA | Name: | (2~{S})-~{N}-(4-aminocarbonylphenyl)oxolane-2-carboxamide | Formula: | C12 H14 N2 O3 | SMILES: | NC(=O)c1ccc(NC(=O)[CH]2CCCO2)cc1 | InChi: | InChI=1S/C12H14N2O3/c13-11(15)8-3-5-9(6-4-8)14-12(16)10-2-1-7-17-10/h3-6,10H,1-2,7H2,(H2,13,15)(H,14,16)/t10-/m0/s1 | Definition date: | 2019-03-15 | Last modified: | 2020-03-20 | Release date: | 2020-03-25 | Identifier: | (2~{S})-~{N}-(4-aminocarbonylphenyl)oxolane-2-carboxamide |
|
 | L5E | Name: | [(7~{S})-1,4-bis(bromanyl)-6,6-bis(oxidanyl)-5,7,8,9-tetrahydrobenzo[7]annulen-7-yl]azanium | Formula: | C11 H14 Br2 N O2 | SMILES: | [NH3+][CH]1CCc2c(Br)ccc(Br)c2CC1(O)O | InChi: | InChI=1S/C11H13Br2NO2/c12-8-2-3-9(13)7-5-11(15,16)10(14)4-1-6(7)8/h2-3,10,15-16H,1,4-5,14H2/p+1/t10-/m0/s1 | Definition date: | 2019-07-22 | Last modified: | 2020-03-20 | Release date: | 2020-03-25 | Identifier: | [(7~{S})-1,4-bis(bromanyl)-6,6-bis(oxidanyl)-5,7,8,9-tetrahydrobenzo[7]annulen-7-yl]azanium |
|
 | M3A | Name: | 5-amino-3-[(4-cyanophenyl)amino]-N-phenyl-1H-1,2,4-triazole-1-carboxamide | Formula: | C16 H13 N7 O | SMILES: | c1(ccc(C#N)cc1)Nc3nc(N)n(C(=O)Nc2ccccc2)n3 | InChi: | InChI=1S/C16H13N7O/c17-10-11-6-8-13(9-7-11)19-15-21-14(18)23(22-15)16(24)20-12-4-2-1-3-5-12/h1-9H,(H,20,24)(H3,18,19,21,22) | Definition date: | 2019-03-19 | Last modified: | 2020-03-20 | Release date: | 2020-03-25 | Identifier: | 5-amino-3-[(4-cyanophenyl)amino]-N-phenyl-1H-1,2,4-triazole-1-carboxamide |
|
 | M3J | Name: | 6-bromo-N~2~-phenylquinazoline-2,4-diamine | Formula: | C14 H11 Br N4 | SMILES: | c3cc(Nc2nc1ccc(Br)cc1c(N)n2)ccc3 | InChi: | InChI=1S/C14H11BrN4/c15-9-6-7-12-11(8-9)13(16)19-14(18-12)17-10-4-2-1-3-5-10/h1-8H,(H3,16,17,18,19) | Definition date: | 2019-03-20 | Last modified: | 2020-03-20 | Release date: | 2020-03-25 | Identifier: | 6-bromo-N~2~-phenylquinazoline-2,4-diamine |
|